Predictors of survival in patients with prostate cancer and spinal metastasis: Presented at the 2009 Joint Spine Section Meeting - Clinical article

Journal of Neurosurgery: Spine

Volumn 13, Issue 6, 2010, Pages 789-794

  Drzymalski, Dan Michael ^a,c   Oh, William K ^b,c,d   Werner, Lillian ^b   Regan, Meredith M ^b,c   Kantoff, Philip ^b,c   Tuli, Sagun ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate cancer; Spinal metastasis; Survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER METASTASIS; BONE METASTASIS; BRAIN METASTASIS; CANCER SURVIVAL; DISEASE DURATION; DISEASE SEVERITY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PREDICTOR VARIABLE; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SOFT TISSUE METASTASIS; SPINAL CORD METASTASIS;

HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS;

EID: 78650224683     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/2010.6.SPINE10167     Document Type: Article

References (21)

1. Albertsen PC, Hanley JA, Gleason DF, Barry MJ: Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280:975-980, 1998
2. Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, et al: Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310-1319, 2009
3. Barcena A, Lobato RD, Rivas JJ, Cordobes F, de Castro S, Cabrera A, et al: Spinal metastatic disease: analysis of factors determining functional prognosis and the choice of treatment. Neurosurgery 15:820-827, 1984 (Pubitemid 15176194)
4. Bilsky MH, Lis E, Raizer J, Lee H, Boland P: The diagnosis and treatment of metastatic spinal tumor. Oncologist 4:459-469, 1999 (Pubitemid 30013180)
5. Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, et al: Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 31:578-583, 2000 (Pubitemid 30323983)
6. Cereceda LE, Flechon A, Droz JP: Management of vertebral metastases in prostate cancer: a retrospective analysis in 119 patients. Clin Prostate Cancer 2:34-40, 2003
7. Gleason DF: Histologic grading and clinical staging of prostatic carcinoma, in Tannenbaum M (ed): Urologic Pathology: The Prostate. Philadelphia: Lea and Febiger, 1977, pp 171-198
8. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
9. Klekamp J, Samii H: Surgical results for spinal metastases. Acta Neurochir 140:957-967, 1998
10. Leithner A, Radl R, Gruber G, Hochegger M, Leithner K, Welkerling H, et al: Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J 17:1488-1495, 2008
11. Lin K, Lipsitz R, Miller T, Janakiraman S: Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 149:192-199, 2008
12. Oh WK, Hayes J, Evan C, Manola J, George DJ, Waldron H, et al: Development of an integrated prostate cancer research information system. Clin Genitourin Cancer 5:61-66, 2006
13. Onimus M, Papin P, Gangloff S: Results of surgical treatment of spinal thoracic and lumbar metastases. Eur Spine J 5:407-411, 1996
14. Potosky AL, Miller BA, Albertsen PC, Kramer BS: The role of increasing detection in the rising incidence of prostate cancer. JAMA 273:548-552, 1995
15. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC: Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281:1591-1597, 1999
16. Rogers CG, Khan MA, Miller MC, Veltri RW, Partin AW: Natural history of disease progression in patients who fail to achieve an undetectable prostate-specific antigen level after undergoing radical prostatectomy. Cancer 101:2549-2556, 2004
17. Scardino PT: The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer. Trans Am Clin Climatol Assoc 111:201-241, 2000
18. Smith JA Jr, Soloway MS, Young MJ: Complications of advanced prostate cancer. Urology 54 (6A Suppl):8-14, 1999
19. Tatsui H, Onomura T, Morishita S, Oketa M, Inoue T: Survival rates of patients with metastatic spinal cancer after scintigraphic detection of abnormal radioactive accumulation. Spine 21:2143-2148, 1996
20. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J: A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 30:2186-2191, 2005
21. Williams BJ, Fox BD, Sciubba DM, Suki D, Tu SM, Kuban D, et al: Surgical management of prostate cancer metastatic to the spine. J Neurosurg Spine 10:414-422, 2009